The Farber’s Disease market size is expected to reach $2.61 billion in 2030 at a CAGR of 5.6%, driven by growing rare genetic disease prevalence.
Read More
The Familial Mediterranean Fever Pharmaceuticals market size is expected to reach $2.21 billion in 2030 at a CAGR of 5.1%, driven by rise in gene therapy.
Read More
The Familial Amyloid Polyneuropathy market size is expected to reach $2.43 billion in 2030 at a CAGR of 8.0%, driven by rising gene therapy focus.
Read More
The Factor XII Inhibitors market size is expected to reach $2.34 billion in 2030 at a CAGR of 10.8%, driven by rising thrombotic disorders incidence.
Read More
The Facet-Joint Injection market size is expected to reach $4.1 billion in 2030 at a CAGR of 6.6%, driven by rising chronic back pain prevalence.
Read More
The Fabry Disease market size is expected to reach $3.27 billion in 2030 at a CAGR of 7.7%, driven by growing focus on personalized medicine.
Read More
The Eylea market size is expected to reach $14.79 billion in 2030 at a CAGR of 7.3%, driven by rising ocular disease prevalence.
Read More
The Eye Drop Mist market size is expected to reach $2.61 billion in 2030 at a CAGR of 11.0%, driven by surge in digital device usage.
Read More
The Eye Allergy Therapeutics market size is expected to reach $4.34 billion in 2030 at a CAGR of 6.0%, driven by rising eye allergy prevalence.
Read More
The Extended-Release Drugs market size is expected to reach $126.89 billion in 2030 at a CAGR of 13.0%, driven by increasing chronic conditions.
Read More